
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Filana Therapeutics (NASDAQ:FLNA) through any online brokerage.
Other companies in Filana Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Filana Therapeutics has a consensus price target of $5.00.
The stock price for Filana Therapeutics (NASDAQ: FLNA) is $0.7 last updated September 15, 2026 at 6:51 PM EDT.
There are no upcoming dividends for Filana Therapeutics.
Filana Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Filana Therapeutics.
Filana Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.